Published in Prog Neuropsychopharmacol Biol Psychiatry on August 13, 2010
Evaluation of depressive symptoms and sleep alterations in college students. Arch Med Res (2005) 1.23
Folate, homocysteine, interleukin-6, and tumor necrosis factor alfa levels, but not the methylenetetrahydrofolate reductase C677T polymorphism, are risk factors for schizophrenia. J Psychiatr Res (2009) 0.96
Basic sleep mechanisms: an integrative review. Cent Nerv Syst Agents Med Chem (2012) 0.92
Impact of early developmental arsenic exposure on promotor CpG-island methylation of genes involved in neuronal plasticity. Neurochem Int (2011) 0.91
Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J Neurochem (2003) 0.86
Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy. Neuropharmacology (2003) 0.85
5-HT1A, 5-HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2/3 somatosensory rat cortex as evaluated by the paired pulse protocol. J Neurosci Res (2004) 0.84
Decreased arginine methylation and myelin alterations in arsenic exposed rats. Neurotoxicology (2009) 0.83
Differential effects of caffeine on the antidepressant-like effect of amitriptyline in female rat subpopulations with low and high immobility in the forced swimming test. Physiol Behav (2008) 0.83
Arsenite-induced formation of hydroxyl radical in the striatum of awake rats. Brain Res (2003) 0.82
Methyl group balance in brain and liver: role of choline on increased S-adenosyl methionine (SAM) demand by chronic arsenic exposure. Toxicol Lett (2012) 0.81
Time course of arsenic species in the brain and liver of mice after oral administration of arsenate. Arch Toxicol (2009) 0.81
Treatment of Parkinson's disease: nanostructured sol-gel silica-dopamine reservoirs for controlled drug release in the central nervous system. Int J Nanomedicine (2010) 0.81
Decreased nitric oxide production in the rat brain after chronic arsenic exposure. Neurochem Res (2006) 0.80
Sustained improvement of motor function in hemiparkinsonian rats chronically treated with low doses of caffeine or trihexyphenidyl. Pharmacol Biochem Behav (2006) 0.80
A novel automated rat catalepsy bar test system based on a RISC microcontroller. J Neurosci Methods (2005) 0.79
Caffeine has greater potency and efficacy than theophylline to reverse the motor impairment caused by chronic but not acute interruption of striatal dopaminergic transmission in rats. Neuropharmacology (2013) 0.79
Quinolinic acid lesions of the pedunculopontine nucleus impair sleep architecture, but not locomotion, exploration, emotionality or working memory in the rat. Behav Brain Res (2011) 0.79
Treatment with subthreshold doses of caffeine plus trihexyphenidyl fully restores locomotion and exploratory activity in reserpinized rats. Neurosci Lett (2004) 0.78
Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems. Free Radic Biol Med (2003) 0.78
The emerging role of the endocannabinoid system in the sleep-wake cycle modulation. Cent Nerv Syst Agents Med Chem (2011) 0.78
Biochemical modulation of the sleep-wake cycle: endogenous sleep-inducing factors. J Neurosci Res (2011) 0.78
A digital programmable telemetric system for recording extracellular action potentials. Behav Res Methods (2009) 0.77
Central nervous system disorders in infants with congenital cytomegalovirus infection. Neurol Res (2010) 0.76
Selective A2A, but not A1 adenosine antagonists enhance the anticataleptic action of trihexyphenidyl in rats. Neurosci Lett (2003) 0.75
Circling behavior induced by microinjection of serotonin reuptake inhibitors in the substantia nigra. Pharmacol Biochem Behav (2002) 0.75
A system for automatic recording and analysis of motor activity in rats. Behav Res Methods (2013) 0.75
Intrahypothalamic Administration of Modafinil Increases Expression of MAP-Kinase in Hypothalamus and Pons in Rats. CNS Neurol Disord Drug Targets (2015) 0.75
Effects of local infusion of methylmercury on the rat brain: GFAP immunohistochemistry and water maze learning. Proc West Pharmacol Soc (2003) 0.75